LABORATORIOS FARMACEUTICOS ROVI, S.A. «...678910...» Page 7 out of 19 15/09/2023 10:27 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 8 September and 14 September 2023 Register number: 24458 08/09/2023 10:22 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 1 September 2023 and 7 September 2023 Register number: 24384 01/09/2023 09:10 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 25 August 2023 and 31 August 2023 Register number: 24280 25/08/2023 09:53 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 18 August and 24 August 2023 Register number: 24207 18/08/2023 11:10 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 11 August 2023 and 17 August 2023 Register number: 24177 11/08/2023 09:41 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 3 August 2023 and 10 August 2023 Register number: 24150 03/08/2023 12:23 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 26 July 2023 and 2 August 2023 Register number: 24066 28/07/2023 09:13 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation ROVI informs on the evaluation process to obtain marketing authorisation for Risvan® Register number: 23963 Related to communication no. 20446 dated 16/02/2023 (08:31) 26/07/2023 08:10 LABORATORIOS FARMACEUTICOS ROVI, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del primer semestre de 2023 Register number: 23799 05/07/2023 08:41 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2023 Register number: 23443 Page 7 out of 19 «...678910...»
